Availability, Accessibility, and Quality of Conservative Kidney Management Worldwide.
Conservative Treatment
/ standards
Decision Making, Shared
Developed Countries
/ statistics & numerical data
Developing Countries
/ statistics & numerical data
Health Services Accessibility
/ statistics & numerical data
Humans
Internationality
Kidney Failure, Chronic
/ therapy
Patient Care Team
/ statistics & numerical data
Quality of Health Care
Religion
Social Support
Surveys and Questionnaires
capacity
conservative kidney management
global health
kidney failure
survey
Journal
Clinical journal of the American Society of Nephrology : CJASN
ISSN: 1555-905X
Titre abrégé: Clin J Am Soc Nephrol
Pays: United States
ID NLM: 101271570
Informations de publication
Date de publication:
31 12 2020
31 12 2020
Historique:
received:
08
06
2020
accepted:
28
10
2020
pubmed:
17
12
2020
medline:
15
12
2021
entrez:
16
12
2020
Statut:
ppublish
Résumé
People with kidney failure typically receive KRT in the form of dialysis or transplantation. However, studies have suggested that not all patients with kidney failure are best suited for KRT. Additionally, KRT is costly and not always accessible in resource-restricted settings. Conservative kidney management is an alternate kidney failure therapy that focuses on symptom management, psychologic health, spiritual care, and family and social support. Despite the importance of conservative kidney management in kidney failure care, several barriers exist that affect its uptake and quality. The Global Kidney Health Atlas is an ongoing initiative of the International Society of Nephrology that aims to monitor and evaluate the status of global kidney care worldwide. This study reports on findings from the 2018 Global Kidney Health Atlas survey, specifically addressing the availability, accessibility, and quality of conservative kidney management. Respondents from 160 countries completed the survey, and 154 answered questions pertaining to conservative kidney management. Of these, 124 (81%) stated that conservative kidney management was available. Accessibility was low worldwide, particularly in low-income countries. Less than half of countries utilized multidisciplinary teams (46%); utilized shared decision making (32%); or provided psychologic, cultural, or spiritual support (36%). One-quarter provided relevant health care providers with training on conservative kidney management delivery. Overall, conservative kidney management is available in most countries; however, it is not optimally accessible or of the highest quality.
Sections du résumé
BACKGROUND AND OBJECTIVES
People with kidney failure typically receive KRT in the form of dialysis or transplantation. However, studies have suggested that not all patients with kidney failure are best suited for KRT. Additionally, KRT is costly and not always accessible in resource-restricted settings. Conservative kidney management is an alternate kidney failure therapy that focuses on symptom management, psychologic health, spiritual care, and family and social support. Despite the importance of conservative kidney management in kidney failure care, several barriers exist that affect its uptake and quality.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS
The Global Kidney Health Atlas is an ongoing initiative of the International Society of Nephrology that aims to monitor and evaluate the status of global kidney care worldwide. This study reports on findings from the 2018 Global Kidney Health Atlas survey, specifically addressing the availability, accessibility, and quality of conservative kidney management.
RESULTS
Respondents from 160 countries completed the survey, and 154 answered questions pertaining to conservative kidney management. Of these, 124 (81%) stated that conservative kidney management was available. Accessibility was low worldwide, particularly in low-income countries. Less than half of countries utilized multidisciplinary teams (46%); utilized shared decision making (32%); or provided psychologic, cultural, or spiritual support (36%). One-quarter provided relevant health care providers with training on conservative kidney management delivery.
CONCLUSIONS
Overall, conservative kidney management is available in most countries; however, it is not optimally accessible or of the highest quality.
Identifiants
pubmed: 33323461
pii: 01277230-202101000-00012
doi: 10.2215/CJN.09070620
pmc: PMC7792657
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
79-87Informations de copyright
Copyright © 2021 by the American Society of Nephrology.
Références
Anand S, Kurella Tamura M, Chertow GM: The elderly patients on hemodialysis. Minerva Urol Nefrol 62: 87–101, 2010
Davison SN, Levin A, Moss AH, Jha V, Brown EA, Brennan F, Murtagh FE, Naicker S, Germain MJ, O’Donoghue DJ, Morton RL, Obrador GT; Kidney Disease Improving Global Outcomes: Executive summary of the Kidney Disease Improving Global Outcomes controversies conference on supportive care in chronic kidney disease: Developing a roadmap to improving quality care. Available at: https://kdigo.org/ . Kidney Int 88: 447–459, 2015 25923985
Brown MA, Crail SM, Masterson R, Foote C, Robins J, Katz I, Josland E, Brennan F, Stallworthy EJ, Siva B, Miller C, Urban AK, Sajiv C, Glavish RN, May S, Langham R, Walker R, Fassett RG, Morton RL, Stewart C, Phipps L, Healy H, Berquier I: ANZSN renal supportive care 2013: Opinion pieces [corrected] [published correction appears in Nephrology (Carlton) 19: 175, 2014]. Nephrology (Carlton) 18: 401–454, 2013 23586687
Davison SN, Tupala B, Wasylynuk BA, Siu V, Sinnarajah A, Triscott J: Recommendations for the care of patients receiving conservative kidney management: Focus on management of CKD and symptoms. Clin J Am Soc Nephrol 14: 626–634, 2019 30819670
Ladin K, Pandya R, Kannam A, Loke R, Oskoui T, Perrone RD, Meyer KB, Weiner DE, Wong JB: Discussing conservative management with older patients with CKD: An interview study of nephrologists. Am J Kidney Dis 71: 627–635, 2018 29396240
Grubbs V, Tuot DS, Powe NR, O’Donoghue D, Chesla CA: System-level barriers and facilitators for foregoing or withdrawing dialysis: A qualitative study of nephrologists in the United States and England. Am J Kidney Dis 70: 602–610, 2017 28242134
Bello AK, Levin A, Lunney M, Osman MA, Ye F, Ashuntantang GE, Bellorin-Font E, Benghanem Gharbi M, Davison SN, Ghnaimat M, Harden P, Htay H, Jha V, Kalantar-Zadeh K, Kerr PG, Klarenbach S, Kovesdy CP, Luyckx VA, Neuen BL, O’Donoghue D, Ossareh S, Perl J, Rashid HU, Rondeau E, See E, Saad S, Sola L, Tchokhonelidze I, Tesar V, Tungsanga K, Turan Kazancioglu R, Wang AY, Wiebe N, Yang CW, Zemchenkov A, Zhao MH, Jager KJ, Caskey F, Perkovic V, Jindal KK, Okpechi IG, Tonelli M, Feehally J, Harris DC, Johnson DW: Status of care for end stage kidney disease in countries and regions worldwide: International cross sectional survey. BMJ 367: l5873, 2019 31672760
Bello AK, Johnson DW, Feehally J, Harris D, Jindal K, Lunney M, Okpechi IG, Salako BL, Wiebe N, Ye F, Tonelli M, Levin A: Global Kidney Health Atlas (GKHA): Design and methods. Kidney Int Suppl (2011) 7: 145–153, 2017 30675429
Bello AK, Levin A, Tonelli M, Okpechi IG, Feehally J, Harris D, Jindal K, Salako BL, Rateb A, Osman MA, Qarni B, Saad S, Lunney M, Wiebe N, Ye F, Johnson DW: Assessment of global kidney health care status. JAMA 317: 1864–1881, 2017 28430830
International Society of Nephrology: Global Kidney Health Atlas. Available at: https://www.theisn.org/in-action/research/global-kidney-health-atlas/ . Accessed August 26, 2019
International Society of Nephrology: Regional Boards. Available at: https://www.theisn.org/about-isn/governance/regional-boards/ . Accessed February 14, 2020
Murtagh FE, Burns A, Moranne O, Morton RL, Naicker S: Supportive care: Comprehensive conservative care in end-stage kidney disease. Clin J Am Soc Nephrol 11: 1909–1914, 2016 27510453
National Institute for Health and Care Excellence: Renal replacement therapy and conservative management. NICE guideline [NG107], 2018. Available at: https://www.nice.org.uk/guidance/ng107 . Accessed September 17, 2019
Harrison TG, Tam-Tham H, Hemmelgarn BR, James MT, Sinnarajah A, Thomas CM: Identification and prioritization of quality indicators for conservative kidney management. Am J Kidney Dis 73: 174–183, 2019 30482578
University of Bristol: Prepare for kidney care trial. Available at: http://www.bristol.ac.uk/population-health-sciences/projects/prepare-kc-trial/ . Accessed September 17, 2019
Alberta Health Services: Conservative Kidney Management (CKM), 2016. Available at: https://www.ckmcare.com . Accessed September 17, 2019
Fortnum D, Smolonogov T, Walker R, Kairaitis L, Pugh D: ‘My kidneys, my choice, decision aid’: Supporting shared decision making. J Ren Care 41: 81–87, 2015 25491064
Davis JL, Davison SN: Hard choices, better outcomes: A review of shared decision-making and patient decision aids around dialysis initiation and conservative kidney management. Curr Opin Nephrol Hypertens 26: 205–213, 2017 28212179
St. George and Sutherland Hospitals, Renal Department: Information for patients about advanced kidney disease: Dialysis and non-dialysis treatments, 2017. Available at: https://stgrenal.org.au/sites/default/files/upload/Predialysis/Patient information about dialysis 2018_V2.pdf. Accessed February 15, 2020
Harris DCH, Davies SJ, Finkelstein FO, Jha V, Donner JA, Abraham G, Bello AK, Caskey FJ, Garcia GG, Harden P, Hemmelgarn B, Johnson DW, Levin NW, Luyckx VA, Martin DE, McCulloch MI, Moosa MR, O’Connell PJ, Okpechi IG, Pecoits Filho R, Shah KD, Sola L, Swanepoel C, Tonelli M, Twahir A, van Biesen W, Varghese C, Yang CW, Zuniga C; Working Groups of the International Society of Nephrology’s 2nd Global Kidney Health Summit: Increasing access to integrated ESKD care as part of universal health coverage. Kidney Int 95: S1–S33, 2019 30904051
Hole B, Hemmelgarn B, Brown E, Brown M, McCulloch MI, Zuniga C, Andreoli SP, Blake PG, Couchoud C, Cueto-Manzano AM, Dreyer G, Garcia G, Jager KJ, McKnight M, Morton RL, Murtagh FEM, Naicker S, Obrador GT, Perl J, Rahman M, Shah KD, Van Biesen W, Walker RC, Yeates K, Zemchenkov A, Zhao MH, Davies SJ, Caskey FJ: Supportive care for end-stage kidney disease: An integral part of kidney services across a range of income settings around the world. Kidney Int Suppl (2011) 10: e86–e94, 2020 32149013